Cost Effectiveness of Onabotulinumtoxina Versus Ptns and Sns for the Treatment of Overactive Bladder from the US Payer Perspective
May 1, 2016, 00:00
10.1016/j.jval.2016.03.534
https://www.valueinhealthjournal.com/article/S1098-3015(16)00602-1/fulltext
Title :
Cost Effectiveness of Onabotulinumtoxina Versus Ptns and Sns for the Treatment of Overactive Bladder from the US Payer Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00602-1&doi=10.1016/j.jval.2016.03.534
First page :
A130
Section Title :
Urinary/Kidney Disorders - Cost Studies
Open access? :
No
Section Order :
192